請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22274
標題: | 遲發性運動障礙之精神病患藥物治療轉換為Aripiprazole之24週追蹤研究 Switching Antipsychotic Treatment to Aripiprazole in Psychotic Patients with Neuroleptic-induced Tardive Dyskinesia: A 24-week Follow-up Study |
作者: | Chia-Hsiang Chan 詹佳祥 |
指導教授: | 程蘊菁(Yen-Ching Chen) |
關鍵字: | 遲發性運動障礙,第二代抗精神病藥物,非典型抗精神病藥物,副作用,錐體外症狀, Tardive dyskinesia,Second generation antipsychotic,side effect, Extrapyramidal symptoms (EPS),aripiprazole, |
出版年 : | 2010 |
學位: | 碩士 |
摘要: | Background and Objective: Aripiprazole is a novel second generation antipsychotics, acting as a partial dopamine D2 receptor agonist, partial 5-HT1A agonist, and 5-HT2A antagonist. Previous studies on aripirazole for tardive dyskinesia (TD) treatment were limited and inconclusive. This study was aimed to examine the change of TD severity via switching antipsychotic treatment to aripiprazole in psychotic patients with a pre-existing TD.
Methods: Thirty psychotic patients with neuroleptic-induced TD were recruited from a psychiatry teaching hospital in northern Taiwan from 2008 to 2010. These patients were cross-titrated of prior antipsychotics with aripiprazole and the severity of TD was assessed at baseline and at weeks 2, 4, 8, 12, 16, 20, and 24. TD was defined according to the research criteria in DSM-IV and was mainly evaluated by Abnormal Involuntary Movement Scale (AIMS). Results: The AIMS total scores significantly decreased from baseline to the end of the 24th week (7.17 ± 5.55). The significant improvement of AIMS total scores started to show up at week 2 (P<.0001) and the change remained significant over time (P<.0001). The greater severity of TD (OR: 1.35, 95% CI 1.04-1.76, P=.03) and a lower severity of parkinsonism (OR: 0.78, 95% CI 0.61-0.99, P=.04) at baseline was significantly associated with a positive treatment response (AIMS scores reduced ≧50%). Conclusion: Our findings implicated that aripiprazole can be a promising treatment for clinicians considering drug switch in patients with TD. Further large controlled trials are warranted. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22274 |
全文授權: | 未授權 |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 660.91 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。